Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/15/26 21:27 | 7/15/26 | PSNL | Health | Health | Medical Laboratories | Chen Richard | CA | O | P,CMO | 3 | S.d | -1,522 | 15.02 | 0 | -101 | 174 | D | |||||||||||||||
7/9/26 20:46 | 7/9/26 | PSNL | Health | Health | Medical Laboratories | Hall Christopher M | CA | DO | CEO | 4 | S.dm | -4,191 | 12.72 | 0 | -330 | 236 | D | |||||||||||||||
6/29/26 17:50 | 7/28/25 | PSNL | Health | Health | Medical Laboratories | Tachibana Aaron | CA | O | CFO,COO | 8 | S.d | -2,817 | 11.65 | 0 | -242 | 199 | D | |||||||||||||||
5/20/25 17:51 | 5/16/25 | PSNL | Health | Health | Medical Laboratories | Moore Stephen Michael | CA | O | SVP,GC | 1 | S | -8 | 4.95 | 0 | -2 | 64 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |